Leading Cardiologists during a Lipicard survey said that they will prescribe PLATROL(R) for long-term cardio-protection. Dr. Zacharia P Zacharia, CEO and President of Fort Lauderdale Heart Institute and Director of Cardiology at Holy Cross Hospital in Fort Lauderdale said that a high therapeutic index drug PLATROL(R) will be prescribed by cardiologists when approved and available. Dr. K. Ram Reddy, Interventional Cardiologist, HCA Bayonet Point Hospital, Florida, a leading Cardiac Surgeon said most of the interventional cardiologists and cardiologists can offer PLATROL(R) to their patients if the drug is available with less toxicity and higher efficacy. Lipicard survey conducted in Florida also included Dr. Hoshedar P. Tamboli, Cardiologist, University of South Florida among other leading cardiologists.
